The influence of sex, race/ethnicity and CYP2B6 genotype on bupropion (B) metabolism.

被引：0
|
作者：
Dic, K. [1 ]
Hogeland, G. [1 ]
Rezk, N. [1 ]
White, N. [1 ]
Lamba, J. [2 ]
Lee, C. [1 ]
Kashuba, A. D. [1 ]
Schuetz, E. G. [2 ]
Lindley, C. M. [1 ]
Chen, M. L. [3 ]
Hawke, R. L. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] St Jude Childrens Hosp, Memphis, TN USA
[3] US FDA, Silver Spring, MD USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S81 / S81
页数：1
相关论文
共 50 条
  • [1] The Influence of Sex, Ethnicity, and CYP2B6 Genotype on Bupropion Metabolism as an Index of Hepatic CYP2B6 Activity in Humans
    Ilic, Katarina
    Hawke, Roy L.
    Thirumaran, Ranjit K.
    Schuetz, Erin G.
    Hull, J. Heyward
    Kashuba, Angela D. M.
    Stewart, Paul W.
    Lindley, Celeste M.
    Chen, Mei-Ling
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (03) : 575 - 581
  • [2] The Influence of Sex, Ethnicity, and CYP2B6 Genotype on Bupropion Metabolism as an Index of Hepatic CYP2B6 Activity in Humans (vol 41, pg 575, 2013)
    IIic, K.
    Hawke, R. L.
    Thirumaran, R. K.
    Schuetz, E. G.
    Hull, J. H.
    Kashuba, A. D.
    Stewart, P. W.
    Lindley, C. M.
    Chen, M. L.
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (07) : 1137 - 1137
  • [3] INFLUENCE OF CYP2B6*6 GENOTYPE ON BUPROPION ENANTIOMERS METABOLISM AND CLEARANCE
    Kharasch, E. D.
    Crafford, A.
    Parchomski, J.
    Blood, J.
    Regina, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S54 - S54
  • [4] Novel CYP2B6 polymorphisms and their impact on efavirenz and bupropion metabolism
    Klein, K.
    Radloff, R.
    Gras, A.
    Masquelier, C.
    Arumugam, K.
    Karasi, J-C
    Seguin-Devaux, C.
    Zanger, U. M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S41 - S41
  • [5] Common Polymorphisms of CYP2B6 Influence Stereoselective Bupropion Disposition
    Kharasch, Evan D.
    Crafford, Amanda
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (01) : 142 - 152
  • [6] CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial
    Lee, Anna M.
    Jepson, Christopher
    Hoffmann, Ewa
    Epstein, Leonard
    Hawk, Larry W.
    Lerman, Caryn
    Tyndale, Rachel F.
    BIOLOGICAL PSYCHIATRY, 2007, 62 (06) : 635 - 641
  • [7] Influence of CYP2B6 Pharmacogenetics on Stereoselective Inhibition and Induction of Bupropion Metabolism by Efavirenz in Healthy Volunteers
    Gufford, Brandon T.
    Metzger, Ingrid F.
    Bamfo, Nadia O.
    Benson, Eric A.
    Masters, Andrea R.
    Lu, Jessica Bo Li
    Desta, Zeruesenay
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2022, 382 (03): : 313 - 326
  • [8] THE EXTENT OF INHIBITION AND INDUCTION OF CYP2B6 BY EFAVRIENZ IS CYP2B6 GENOTYPE-DEPENDENT
    Duong, A.
    Gufford, B.
    Masters, A.
    Burgess, K.
    Lu, J.
    Metzger, I.
    Desta, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S36 - S36
  • [9] Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolism
    Crane, Alice L.
    Klein, Kathrin
    Zanger, Ulrich M.
    Olson, James R.
    TOXICOLOGY, 2012, 293 (1-3) : 115 - 122
  • [10] CYP2B6 mediates the in vitro biotransformation of bupropion to hydroxybupropion
    Hesse, LM
    Court, MH
    von Moltke, LL
    Shader, RI
    Greenblatt, DJ
    FASEB JOURNAL, 2000, 14 (08): : A1336 - A1336
12345